Realm Therapeutics (RLM)

Sector:

Health Care

Trade now with BarclaysStockbrokers Trade now with Barclays Sponsored by Barclays Stockbrokers

7.50p
   
  • Change Today:
    -0.20p
  • 52 Week High: 48.00
  • 52 Week Low: 7.50
  • Currency: UK Pounds
  • Shares Issued: 116.56m
  • Volume: 55,000
  • Market Cap: 8.74m
  • Beta: 0.24

RLM Overview

Realm Therapeutics is an emerging specialty biopharmaceutical company focused on developing novel immunomodulatory therapies to protect and improve the lives of adults and children. The Company has initiated drug development programmes, based on its proprietary hypochlorous acid technology at high concentrations. The Company believes their formulations have novel immunomodulatory activity with potential application for the treatment of diseases in a number of therapeutic areas including Dermatology and Ophthalmology.

1 Day Chart (14-12-2018)

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -954.5% n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 9.8 n/a
Pr/Book 0.3  
Latest F'cast
Revenue 28.7% n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

RLM Fundamentals

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-13 31.46 (8.62) (6.00)¢ n/a n/a n/a n/a 0.0%
31-Dec-14 17.15 (7.02) (0.14)¢ n/a n/a n/a n/a 0.0%
31-Dec-15 1.23 (5.20) (0.10)¢ n/a n/a n/a n/a 0.0%
31-Dec-16 0.87 (7.30) (0.15)¢ n/a n/a n/a n/a 0.0%
31-Dec-17 1.12 (10.63) (0.16)¢ n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

RLM Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-18 n/a n/a n/a n/a n/a n/a n/a 0.0%
31-Dec-19 n/a n/a n/a n/a n/a n/a n/a 0.0%

Copyright © 2018 FactSet Research Systems Inc. All rights reserved.

Latest RLM Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

RLM Market Data

Currency UK Pounds
Share Price 7.50p
Change Today -0.20p
% Change -2.60 %
52 Week High 48.00
52 Week Low 7.50
Volume 55,000
Shares Issued 116.56m
Market Cap 8.74m
Beta 0.24

RLM Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
65.65% above the market average65.65% above the market average65.65% above the market average65.65% above the market average65.65% above the market average
70.59% above the sector average70.59% above the sector average70.59% above the sector average70.59% above the sector average70.59% above the sector average
Price Trend
95.14% below the market average95.14% below the market average95.14% below the market average95.14% below the market average95.14% below the market average
94.74% below the sector average94.74% below the sector average94.74% below the sector average94.74% below the sector average94.74% below the sector average
Income Not Available
Growth
24.71% below the market average24.71% below the market average24.71% below the market average24.71% below the market average24.71% below the market average
41.18% below the sector average41.18% below the sector average41.18% below the sector average41.18% below the sector average41.18% below the sector average

RLM Dividends

No dividends found

Trades for 14-Dec-2018

Time Volume / Share Price
15:17 55,000 @ 7.00p

Top of Page